Exponent (EXPO) EBITDA Margin (2010 - 2026)

Exponent (EXPO) has reported EBITDA Margin for 17 consecutive years, with 16.33% the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, EBITDA Margin rose 423.0% year-over-year to 16.33%; the trailing twelve-month figure through Jul 2026 stood at 20.17% (down 29.0% YoY), and the FY2026 full-year result was 20.58%, down 82.0% from the prior year.
• EBITDA Margin eased to 16.33% in Q3 2026 per EXPO's latest filing, from 24.88% in the prior quarter.
• Across five years, EBITDA Margin topped out at 34.75% in Q3 2022 and bottomed at 12.1% in Q3 2025.
• Historically, EBITDA Margin has averaged 22.27% across 5 years, with a median of 20.97% in 2024.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 1025 bps in 2022, then tumbled 1345 bps in 2023.
• Over 5 years, EBITDA Margin stood at 17.3% in 2022, then slipped by 13 bps to 14.97% in 2023, then increased by 27 bps to 18.97% in 2024, then climbed by 4 bps to 19.74% in 2025, then declined by 17 bps to 16.33% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 16.33%, 24.88%, and 19.77% for Q3 2026, Q2 2026, and Q1 2026 respectively.